Tissues of human renal cell carcinoma and of its lymph-node metastases were transplanted between the 1st and the 4th passage on 80 nu/nu mice. Growth of tumor was observed in all cases. Chromosomal analyses proved the tumor origin of the transplants. The primary tumor showed two histological patterns: a granular solid cell carcinoma and sarcomatoid elements. The lymph nodes showed only sarcomatoid tissue of the primary tumor. Light-and electron-microscopic examinations showed that the transplanted tumor contained only the sarcomatoid tissue of the original tumor. The solid carcinomatous tissue was not found and, therefore, probably not transplanted. Flow cytometric investigations of the primary tumor revealed two cell populations with a DNA content of 6 and 10.8 pg. Both cell colonies were also discovered in the transplanted tumors as well. The transplants of the primary tumors grew significantly slower than those of the lymph-node metastases. After an initial inert phase, the transplanted tumors grew more rapidly in the male than in the female animals. Neither hematogenous nor lymphatic metastases were observed. After local excision, recurrent tumor development was found in 80% of the experimental animals.

Keywords:
Renal cell carcinoma, nu/nu Mouse, Transplantation
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.